Gastrointestinal Complications of Solid Organ and Hematopoietic Cell Transplantation

Natasha Chandok, Kymberly D S Watt

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Solid organ transplantation (SOT) and hematopoietic cell transplantation (HCT) have dramatically improved the survival and quality of life in patients with a variety of malignancies and chronic end-organ disease. Gastrointestinal (GI) complications occur in almost 40% of solid organ recipients, and similarly account for many of the non-allograft related adverse outcomes in the HCT population. GI disorders are frequently present prior to transplant and immunosuppression may augment symptoms. Immunosuppressive drugs also have notable GI side effects, and immunosuppression predisposes patients to infections and malignancies of the liver and GI tract. Graft vs host disease presents with GI manifestations and can occur following SOT but is more frequently seen after HCT. Sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease (VOD), an immunosuppression regimen-related toxicity, has been reported in SOT, but is also more often seen in the HCT population. GI complications are a prevailing source of morbidity and mortality in solid organ and bone marrow transplant recipients. The gastroenterologist should have a broad clinical approach to these complex patients with a low threshold for endoscopy as histopathology is often necessary for diagnosis and management of these patients

Original languageEnglish (US)
Title of host publicationPractical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas
PublisherWiley-Blackwell
Pages482-490
Number of pages9
ISBN (Print)9781405182744
DOIs
StatePublished - Aug 31 2010

Fingerprint

Cell Transplantation
Organ Transplantation
Immunosuppression
Hepatic Veno-Occlusive Disease
Graft vs Host Disease
Immunosuppressive Agents
Population
Endoscopy
Gastrointestinal Tract
Neoplasms
Bone Marrow
Quality of Life
Morbidity
Transplants
Survival
Mortality
Liver
Infection
Pharmaceutical Preparations

Keywords

  • Complications
  • Gastrointestinal
  • Hepatic
  • Immunosuppression
  • Side effects
  • Transplantation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chandok, N., & Watt, K. D. S. (2010). Gastrointestinal Complications of Solid Organ and Hematopoietic Cell Transplantation. In Practical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas (pp. 482-490). Wiley-Blackwell. https://doi.org/10.1002/9781444328417.ch65

Gastrointestinal Complications of Solid Organ and Hematopoietic Cell Transplantation. / Chandok, Natasha; Watt, Kymberly D S.

Practical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas. Wiley-Blackwell, 2010. p. 482-490.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chandok, N & Watt, KDS 2010, Gastrointestinal Complications of Solid Organ and Hematopoietic Cell Transplantation. in Practical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas. Wiley-Blackwell, pp. 482-490. https://doi.org/10.1002/9781444328417.ch65
Chandok N, Watt KDS. Gastrointestinal Complications of Solid Organ and Hematopoietic Cell Transplantation. In Practical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas. Wiley-Blackwell. 2010. p. 482-490 https://doi.org/10.1002/9781444328417.ch65
Chandok, Natasha ; Watt, Kymberly D S. / Gastrointestinal Complications of Solid Organ and Hematopoietic Cell Transplantation. Practical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas. Wiley-Blackwell, 2010. pp. 482-490
@inbook{2748f33b48f748ac9605515e6908ffc1,
title = "Gastrointestinal Complications of Solid Organ and Hematopoietic Cell Transplantation",
abstract = "Solid organ transplantation (SOT) and hematopoietic cell transplantation (HCT) have dramatically improved the survival and quality of life in patients with a variety of malignancies and chronic end-organ disease. Gastrointestinal (GI) complications occur in almost 40{\%} of solid organ recipients, and similarly account for many of the non-allograft related adverse outcomes in the HCT population. GI disorders are frequently present prior to transplant and immunosuppression may augment symptoms. Immunosuppressive drugs also have notable GI side effects, and immunosuppression predisposes patients to infections and malignancies of the liver and GI tract. Graft vs host disease presents with GI manifestations and can occur following SOT but is more frequently seen after HCT. Sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease (VOD), an immunosuppression regimen-related toxicity, has been reported in SOT, but is also more often seen in the HCT population. GI complications are a prevailing source of morbidity and mortality in solid organ and bone marrow transplant recipients. The gastroenterologist should have a broad clinical approach to these complex patients with a low threshold for endoscopy as histopathology is often necessary for diagnosis and management of these patients",
keywords = "Complications, Gastrointestinal, Hepatic, Immunosuppression, Side effects, Transplantation",
author = "Natasha Chandok and Watt, {Kymberly D S}",
year = "2010",
month = "8",
day = "31",
doi = "10.1002/9781444328417.ch65",
language = "English (US)",
isbn = "9781405182744",
pages = "482--490",
booktitle = "Practical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Gastrointestinal Complications of Solid Organ and Hematopoietic Cell Transplantation

AU - Chandok, Natasha

AU - Watt, Kymberly D S

PY - 2010/8/31

Y1 - 2010/8/31

N2 - Solid organ transplantation (SOT) and hematopoietic cell transplantation (HCT) have dramatically improved the survival and quality of life in patients with a variety of malignancies and chronic end-organ disease. Gastrointestinal (GI) complications occur in almost 40% of solid organ recipients, and similarly account for many of the non-allograft related adverse outcomes in the HCT population. GI disorders are frequently present prior to transplant and immunosuppression may augment symptoms. Immunosuppressive drugs also have notable GI side effects, and immunosuppression predisposes patients to infections and malignancies of the liver and GI tract. Graft vs host disease presents with GI manifestations and can occur following SOT but is more frequently seen after HCT. Sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease (VOD), an immunosuppression regimen-related toxicity, has been reported in SOT, but is also more often seen in the HCT population. GI complications are a prevailing source of morbidity and mortality in solid organ and bone marrow transplant recipients. The gastroenterologist should have a broad clinical approach to these complex patients with a low threshold for endoscopy as histopathology is often necessary for diagnosis and management of these patients

AB - Solid organ transplantation (SOT) and hematopoietic cell transplantation (HCT) have dramatically improved the survival and quality of life in patients with a variety of malignancies and chronic end-organ disease. Gastrointestinal (GI) complications occur in almost 40% of solid organ recipients, and similarly account for many of the non-allograft related adverse outcomes in the HCT population. GI disorders are frequently present prior to transplant and immunosuppression may augment symptoms. Immunosuppressive drugs also have notable GI side effects, and immunosuppression predisposes patients to infections and malignancies of the liver and GI tract. Graft vs host disease presents with GI manifestations and can occur following SOT but is more frequently seen after HCT. Sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease (VOD), an immunosuppression regimen-related toxicity, has been reported in SOT, but is also more often seen in the HCT population. GI complications are a prevailing source of morbidity and mortality in solid organ and bone marrow transplant recipients. The gastroenterologist should have a broad clinical approach to these complex patients with a low threshold for endoscopy as histopathology is often necessary for diagnosis and management of these patients

KW - Complications

KW - Gastrointestinal

KW - Hepatic

KW - Immunosuppression

KW - Side effects

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=84885500074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885500074&partnerID=8YFLogxK

U2 - 10.1002/9781444328417.ch65

DO - 10.1002/9781444328417.ch65

M3 - Chapter

AN - SCOPUS:84885500074

SN - 9781405182744

SP - 482

EP - 490

BT - Practical Gastroenterology and Hepatology: Small and Large Intestine and Pancreas

PB - Wiley-Blackwell

ER -